KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:TYME
Delisted

Tyme Technologies Inc Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.311
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Dec 20, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 19, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 16, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 15, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 14, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 13, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 12, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 09, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 08, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 07, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 06, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 05, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 02, 2022 $0.311 $0.311 $0.311 $0.311 0
Dec 01, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 30, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 29, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 28, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 25, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 23, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 22, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 21, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 18, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 17, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 16, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 15, 2022 $0.311 $0.311 $0.311 $0.311 0
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT